Exelixis, Inc. (EXEL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Exelixis, Inc. (EXEL)

EXEL 44.17

-0.1%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr.praveen who wrote (216)	1/6/2006 5:10:27 PM
From: rkrw	Read Replies (1) of 930

Praveen, I don't think it's likely. At the least ands shareholders will want to find out of their hcv drug is a winner first. If not, then all bets are off. What's ironic is the business models are so different. ands spends judiciously with a great balance sheet. exel hasn't spared any cost and has a complex balance sheet.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next